Engineered Phage Therapies

Engineered Phage Therapies is a biotechnology company focused on developing next-generation bacteriophage treatments to combat the global crisis of antibiotic resistance. The company utilizes advanced genetic engineering and synthetic biology to modify naturally occurring phages, enhancing their host range, stability, and lytic efficiency against multi-drug resistant pathogens. By creating precision-engineered microbial therapies, the company aims to provide highly specific alternatives to traditional antibiotics that minimize disruption to the human microbiome. Their current research focuses on addressing high-unmet-need infections caused by ESKAPE pathogens in clinical and hospital settings.